Results 91 to 100 of about 40,760 (162)

Predicting the ritonavir crisis by revisiting the polymorph landscape with crystal structure prediction and form 4 structure solution. [PDF]

Commun Chem
Iuzzolino L, Kelly AW, Chaudhry MT, Jandl C, Stam D, Lee AY.   +5 more
europepmc   +1 more source

Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database. [PDF]

Ther Adv Drug Saf
Xiong X, Chen Z, Yan B.
europepmc   +1 more source

Effectiveness comparison of nirmatrelvir/ritonavir versus molnupiravir in COVID-19 patients with comorbidities in Taiwan: a multi-centre electronic health record study. [PDF]

BMC Infect Dis
Lin WK, Lin SJ, Chang YH, Wang FD, Nguyen PA, Phuc PT, Burton W, Hien NTK, Lin CC, Lam CS, Ha TC, Lu CY, Huang CW, Yang HC, Lin SM, Yang C, Wang LH, Hsu JC.   +17 more
europepmc   +1 more source

Addressing model overcomplexity in drug-drug interaction prediction with molecular fingerprints. [PDF]

J Cheminform
Gil-Sorribes M, Molina A.
europepmc   +1 more source

HIV-1 drug resistance among HIV/HCV co-infected patients with treatment failure in Yunnan, southwestern China: a cross-sectional study. [PDF]

Front Microbiol
Li H, Ma X, Li Y, He C, Zou F, Kang X, Zhong M.   +6 more
europepmc   +1 more source

Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study. [PDF]

Nat Commun
Guo Z, Wei Y, Lin G, Jia KM, Boyer C, Wang H, Li C, Hung CT, Yam CHK, Chow TY, Zhao S, Li K, Yang A, Mok CKP, Hui DS, Yeoh EK, Chong KC.   +16 more
europepmc   +1 more source

Optimized Milling Approaches for Scalable Production of Ritonavir Nanocrystals: from Process Design to Bioperformance Evaluation. [PDF]

ACS Omega
da Cunha Chaves MH, Alexandrino-Júnior F, Sarcinelli MA, Gomes-da-Silva NC, Santos-Oliveira R, Amendoeira FC, Antunes Rocha HV.   +6 more
europepmc   +1 more source

Eligibility for Nirmatrelvir/Ritonavir Among Adults With an Acute Care COVID-19 Encounter: A Retrospective Cohort Study From Alberta, Canada. [PDF]

Pharmacoepidemiol Drug Saf
Aponte-Hao S, Vu K, Randall JR, Martins KJB, Nguyen PU, Saxinger L, Leal J, Rennert-May E, Rafferty E, Williamson T, Klarenbach SW.   +10 more
europepmc   +1 more source

Advancements in development of novel class of HIV protease inhibitors. [PDF]

Ann Med
Gu WG, Yin GZ, Zhang YP.
europepmc   +1 more source

Paxlovid utilization and social vulnerability: trends in Connecticut from 2022 to 2023. [PDF]

Antimicrob Steward Healthc Epidemiol
Hohenstein L, Maloney M, Banach DB.
europepmc   +1 more source